Background. In Egypt, the prevalence of chronic hepatitis C (CHC) infection is 13.8% of
whole population and about 80% of the patients with hepatocellular carcinoma have …

Objectives: In the setting of surveillance for hepatocellular carcinoma (HCC) detection, the
use of serum biomarkers in addition to ultrasonography (US) is still a matter of debate …

Metabolomics has been shown to be an effective tool for disease diagnosis, biomarker
screening and characterization of biological pathways. A total of 140 subjects were included …

Conflicting results for circulating glypican-3 (GPC3) were reported in hepatocellular
carcinoma (HCC) diagnosis. We aimed to improve the diagnostic power of GPC3 by …

Background and aims Several angiogenic factors are involved in the development and
progression of hepatocellular carcinoma (HCC), a hypervascular tumor. Vascular …

Objectives The aim of this study was to assess serum levels of endocan & VEGF in patients
with hepatitis C virus-related HCC and their diagnostic and predictive value of mortality …

Background: Hepatocellular carcinoma (HCC) accounts for more than 80% of primary liver
cancers. Moreover, in the next 10 years, more than one million patients are expected to die …

Objectives: Hepatocellular carcinoma (HCC) is a primary malignancy of the liver and a
global health problem. It is often diagnosed at advanced stage where hopeless for effective …

Background/aims Hepatocellular carcinoma (HCC) is a primary malignancy of the liver and
a global health problem. It is often diagnosed at advanced stage where hopeless for …

Hepatitis C is the major cause for progressive liver disease, and afflicts approximately 158
million individuals globally 1, 2. It is estimated that between 2007 and 2009, the costs of …